{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:07:31Z","timestamp":1778936851218,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053136"],"award-info":[{"award-number":["R01DA053136"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA036297"],"award-info":[{"award-number":["U01DA036297"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31DA054849"],"award-info":[{"award-number":["F31DA054849"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020940","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["10P30AI094189"],"award-info":[{"award-number":["10P30AI094189"]}],"id":[{"id":"10.13039\/100020940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["10P30AI094189"],"award-info":[{"award-number":["10P30AI094189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI102623"],"award-info":[{"award-number":["T32AI102623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.dadr.2023.100184","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T12:49:33Z","timestamp":1691585373000},"page":"100184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2174-5004","authenticated-orcid":false,"given":"Eshan U.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky L.","family":"Genberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine G.","family":"Schluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquie","family":"Astemborski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinaldo E.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Laeyendecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dadr.2023.100184_bib0001","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10654-021-00727-7","article-title":"How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19","volume":"36","author":"Accorsi","year":"2021","journal-title":"Eur. J. Epidemiol."},{"issue":"48","key":"10.1016\/j.dadr.2023.100184_bib0002","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.15585\/mmwr.mm7148a4","article-title":"SARS-CoV-2 serology and self-reported infection among adults\u2014national health and nutrition examination survey, United States, August 2021-May 2022","volume":"71","author":"Akinbami","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"10252","key":"10.1016\/j.dadr.2023.100184_bib0003","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S0140-6736(20)31823-7","article-title":"Surveillance is underestimating the burden of the COVID-19 pandemic","volume":"396","author":"Alwan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dadr.2023.100184_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajem.2022.03.048","article-title":"Opioid usage and COVID-19 prognosis: a systematic review and meta-analysis","volume":"56","author":"Ao","year":"2022","journal-title":"Am. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.dadr.2023.100184_bib0005","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7326\/M20-7547","article-title":"Antibody response after SARS-CoV-2 Infection and Implications for Immunity","volume":"174","author":"Arkhipova-Jenkins","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.dadr.2023.100184_bib0006","doi-asserted-by":"crossref","first-page":"e35066","DOI":"10.2196\/35066","article-title":"How vaccine ambivalence can lead people who inject drugs to decline covid-19 vaccination and ways this can be addressed: qualitative study","volume":"6","author":"Aronson","year":"2022","journal-title":"JMIR Format. Res."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0007","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/S2468-2667(21)00235-8","article-title":"Safeguarding people living in vulnerable conditions in the COVID-19 era through universal health coverage and social protection","volume":"7","author":"Barron","year":"2022","journal-title":"Lancet Public Health"},{"issue":"11","key":"10.1016\/j.dadr.2023.100184_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004107","article-title":"Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies","volume":"19","author":"Bergeri","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.dadr.2023.100184_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103889","article-title":"A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic","volume":"110","author":"Bradley","year":"2022","journal-title":"Int. J. Drug Policy"},{"issue":"7","key":"10.1016\/j.dadr.2023.100184_bib0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"16","key":"10.1016\/j.dadr.2023.100184_bib0011","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking","volume":"158","author":"Bush","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.dadr.2023.100184_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104060","article-title":"The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: a qualitative study in St. Petersburg, Russia","volume":"117","author":"Carroll","year":"2023","journal-title":"Int. J. Drug Policy"},{"issue":"5","key":"10.1016\/j.dadr.2023.100184_bib0013","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/00333549221110299","article-title":"COVID-19 vaccine hesitancy and vaccination status in a community-based cohort of people who inject drugs in Baltimore, Maryland, March-June 2021","volume":"137","author":"Cepeda","year":"2022","journal-title":"Public Health Rep."},{"key":"10.1016\/j.dadr.2023.100184_bib0014","article-title":"COVID-19 vaccine deliberation among people who inject drugs","volume":"3","author":"Cioffi","year":"2022","journal-title":"Drug Alcohol Depend. Rep."},{"issue":"9","key":"10.1016\/j.dadr.2023.100184_bib0015","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3201\/eid2609.201840","article-title":"Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity","volume":"26","author":"Clapham","year":"2020","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.dadr.2023.100184_bib0016","unstructured":"CRISP. (n.d.). Chesapeake Regional Information System for Our Patients (CRISP) is the State Designated Health Information Exchange (HIE) for Maryland. Retrieved January 18, 2023, from https:\/\/www.crisphealth.org\/."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12954-023-00791-0","article-title":"COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City","volume":"20","author":"Des Jarlais","year":"2023","journal-title":"Harm. Reduct. J."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12954-023-00754-5","article-title":"SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya","volume":"20","author":"Doshi","year":"2023","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2023.100184_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108584","article-title":"The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: a rapid phone survey in Baltimore, Maryland","volume":"221","author":"Genberg","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100184_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109622","article-title":"Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV","volume":"241","author":"Gorbach","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100184_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.931306","article-title":"COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico","volume":"10","author":"Harvey-Vera","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.dadr.2023.100184_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109383","article-title":"Substance use disorders and COVID-19: an analysis of nation-wide veterans health administration electronic health records","volume":"234","author":"Hasin","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2023.100184_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108806","article-title":"Multimorbidity classes indicate differential patterns of health care engagement among people who inject drugs","volume":"142","author":"Heidari","year":"2022","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/M22-1745","article-title":"Major update 2: antibody response and risk for reinfection after SARS-CoV-2 infection\u2014final update of a living, rapid review","volume":"176","author":"Holmer","year":"2023","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12954-022-00643-3","article-title":"Uptake of COVID-19 vaccination among people who inject drugs","volume":"19","author":"Iversen","year":"2022","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2023.100184_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.15161","article-title":"Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021","author":"Jones","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2023.100184_bib0027","doi-asserted-by":"crossref","unstructured":"Krawczyk, N., Rivera, B.D., Basaraba, C., Corbeil, T., Allen, B., Schultebraucks, K., Henry, B.F., Pincus, H.A., Levin, F.R., & Martinez, D. 2023. COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems. Addiction, n\/a(n\/a). 10.1111\/add.16105.","DOI":"10.1111\/add.16105"},{"issue":"23","key":"10.1016\/j.dadr.2023.100184_bib0028","doi-asserted-by":"crossref","first-page":"757","DOI":"10.15585\/mmwr.mm7123a2","article-title":"COVID-19 vaccination coverage, by race and ethnicity\u2014national immunization survey adult COVID Module, United States, December 2020-November 2021","volume":"71","author":"Kriss","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"10.1016\/j.dadr.2023.100184_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266663","article-title":"Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID) infections in persons who inject drugs","volume":"17","author":"Lim","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-021-00499-z","article-title":"Health literacy and changes in pattern of drug use among participants at the stockholm needle exchange program during the COVID-19 pandemic","volume":"18","author":"Lindqvist","year":"2021","journal-title":"Harm. Reduct. J."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03647-20","article-title":"Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis","volume":"12","author":"Ng","year":"2021","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.dadr.2023.100184_bib0032","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/M20-6976","article-title":"The proportion of SARS-CoV-2 infections that are asymptomatic","volume":"174","author":"Oran","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000399","article-title":"Defining representativeness of study samples in medical and population health research","volume":"2","author":"Rudolph","year":"2023","journal-title":"BMJ Med."},{"issue":"3","key":"10.1016\/j.dadr.2023.100184_bib0034","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3201\/eid2803.211885","article-title":"Evaluation of commercially available high-throughput SARS-CoV-2 serologic assays for serosurveillance and related applications","volume":"28","author":"Stone","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.dadr.2023.100184_bib0035","doi-asserted-by":"crossref","first-page":"ofad392","DOI":"10.1093\/ofid\/ofad392","article-title":"A brief peer-led intervention to increase COVID-19 vaccine uptake among people who inject drugs in San Diego County: results from a pilot randomized controlled trial","author":"Strathdee","year":"2023","journal-title":"Open Forum Infect Dis."},{"issue":"11","key":"10.1016\/j.dadr.2023.100184_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260286","article-title":"Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region","volume":"16","author":"Strathdee","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.dadr.2023.100184_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2023.01.042","article-title":"Predictors of COVID-19 vaccine uptake among people who inject drugs","author":"Strathdee","year":"2023","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.dadr.2023.100184_bib0038","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/add.15659","article-title":"Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA","volume":"117","author":"Sun","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2023.100184_bib0039","article-title":"COVID-19 vaccination acceptability and experiences among people who inject drugs in San Diego County","volume":"30","author":"Valasek","year":"2022","journal-title":"Prev. Med. Rep."},{"issue":"4","key":"10.1016\/j.dadr.2023.100184_bib0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/002204269102100406","article-title":"The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods","volume":"21","author":"Vlahov","year":"1991","journal-title":"J. Drug Issues"},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0041","article-title":"Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0042","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.dadr.2023.100184_bib0043","article-title":"Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022","volume":"18","author":"Wiegand","year":"2023","journal-title":"Lancet Reg.Health"},{"issue":"4","key":"10.1016\/j.dadr.2023.100184_bib0044","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s10461-022-03851-x","article-title":"Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel","volume":"27","author":"Wiessing","year":"2023","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.dadr.2023.100184_bib0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1186\/s12889-022-13273-y","article-title":"A cross-sectional study of factors associated with COVID-19 testing among people who inject drugs: missed opportunities for reaching those most at risk","volume":"22","author":"Yeager","year":"2022","journal-title":"BMC Public Health"}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:13:52Z","timestamp":1778933632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724623000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"alternative-id":["S2772724623000549"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100184","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100184"}}